Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments

por Mohamed, Ateesha F., González, Juan Marcos, Fairchild, Angelyn
Publicado 2015

Public preferences for the return of research results in genetic research: A conjoint analysis

por Bollinger, Juli, Bridges, John F P, Mohamed, Ateesha, Kaufman, David
Publicado 2014

Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection

por Kauf, Teresa L., Mohamed, Ateesha F., Hauber, A. Brett, Fetzer, Derek, Ahmad, Atiya
Publicado 2012

Understanding what matters to metastatic castration‐resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey

por George, Daniel J., Mohamed, Ateesha F., Tsai, Jui‐Hua, Karimi, Milad, Ning, Ning, Jayade, Sayeli, Botteman, Marc
Publicado 2022

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

por Srinivas, Sandy, Mohamed, Ateesha F., Appukkuttan, Sreevalsa, Botteman, Marc, Ng, Xinyi, Joshi, Namita, Horodniceanu, Erica, Waldeck, A. Reginald, Simmons, Stacey J
Publicado 2020

Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors

por Qian, Yi, Arellano, Jorge, Hauber, A. Brett, Mohamed, Ateesha F., Gonzalez, Juan Marcos, Hechmati, Guy, Gatta, Francesca, Harrelson, Stacey, Campbell-Baird, Cynthia
Publicado 2016

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom

por Qian, Yi, Arellano, Jorge, Gatta, Francesca, Hechmati, Guy, Hauber, A. Brett, Mohamed, Ateesha F., Bahl, Amit, von Moos, Roger, Body, Jean-Jacques
Publicado 2018

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom

por Hechmati, Guy, Hauber, A. Brett, Arellano, Jorge, Mohamed, Ateesha F., Qian, Yi, Gatta, Francesca, Haynes, Ian, Bahl, Amit, von Moos, Roger, Body, Jean-Jacques
Publicado 2014

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment

por Srinivas, Sandy, Mohamed, Ateesha F., Appukkuttan, Sreevalsa, Botteman, Marc, Ng, Xinyi, Joshi, Namita, Tsai, Jui‐Hua, Fang, Jarjieh, Waldeck, A. Reginald, Simmons, Stacey J.
Publicado 2020

Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment

por Uemura, Hiroji, Matsubara, Nobuaki, Kimura, Go, Yamaguchi, Akito, Ledesma, Dianne Athene, DiBonaventura, Marco, Mohamed, Ateesha F., Basurto, Enrique, McKinnon, Ian, Wang, Ed, Concialdi, Kristen, Narimatsu, Aya, Aitoku, Yasuko
Publicado 2016

Erratum to: Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment

por Uemura, Hiroji, Matsubara, Nobuaki, Kimura, Go, Yamaguchi, Akito, Ledesma, Dianne Athene, DiBonaventura, Marco, Mohamed, Ateesha F., Basurto, Enrique, McKinnon, Ian, Wang, Ed, Concialdi, Kristen, Narimatsu, Aya, Aitoku, Yasuko
Publicado 2017